BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
- Company reached alignment with the U.S. FDA on the Chemistry, Manufacturing, and Controls (CMC) aspects of its planned Phase 3b clinical trial…
